High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease.

Rosa Di MussiSavino SpadaroTania StripoliCarlo Alberto VoltaPaolo TrerotoliPaola PierucciFrancesco StaffieriFrancesco BrunoLuigi CamporotaSalvatore Grasso

Published in: Critical care (London, England) (2018)

In patients with COPD, the application of HFNC postextubation significantly decreased the neuroventilatory drive and work of breathing compared with conventional O2 therapy.

Keyphrases

chronic obstructive pulmonary disease
extracorporeal membrane oxygenation
stem cells
lung function
respiratory failure
cell therapy
acute respiratory distress syndrome
chronic rhinosinusitis